174 related articles for article (PubMed ID: 36554267)
1. The Direct and Indirect Costs of Breast Cancer in Poland: Estimates for 2017-2019.
Seweryn M; Banas T; Augustynska J; Lorenc O; Kopel J; Pluta E; Skora T
Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554267
[TBL] [Abstract][Full Text] [Related]
2. Productivity losses and public finance burden attributable to breast cancer in Poland, 2010-2014.
Łyszczarz B; Nojszewska E
BMC Cancer; 2017 Oct; 17(1):676. PubMed ID: 29017454
[TBL] [Abstract][Full Text] [Related]
3. Economic and social cost of epilepsy in Poland: 5-year analysis.
Jędrzejczak J; Majkowska-Zwolińska B; Chudzicka-Bator A; Żerda I; Władysiuk M; Godman B
Eur J Health Econ; 2021 Apr; 22(3):485-497. PubMed ID: 33582892
[TBL] [Abstract][Full Text] [Related]
4. Costs of diabetes and its complications in Poland.
Leśniowska J; Schubert A; Wojna M; Skrzekowska-Baran I; Fedyna M
Eur J Health Econ; 2014 Jul; 15(6):653-60. PubMed ID: 23820625
[TBL] [Abstract][Full Text] [Related]
5. The direct and indirect costs of epilepsy in Poland estimates for 2014-2016 years.
Mela A; Staniszewska A; Wrona W; Poniatowski ŁA; Jaroszyński J; Niewada M
Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):353-362. PubMed ID: 30293466
[TBL] [Abstract][Full Text] [Related]
6. The impacts of the COVID-19 pandemic on indirect costs of mental illness and behavioral disorders in Poland.
Sobczyk K; Holecki T; Rogalska A
Front Public Health; 2023; 11():1207389. PubMed ID: 37790719
[TBL] [Abstract][Full Text] [Related]
7. The indirect costs of systemic autoimmune diseases, systemic lupus erythematosus, systemic sclerosis and sarcoidosis: a summary of 2012 real-life data from the Social Insurance Institution in Poland.
Kawalec PP; Malinowski KP
Expert Rev Pharmacoecon Outcomes Res; 2015; 15(4):667-73. PubMed ID: 26153642
[TBL] [Abstract][Full Text] [Related]
8. The cost of newly diagnosed breast cancer in Lithuania, 2011.
Ivanauskienė R; Domeikienė A; Kregždytė R; Milašauskienė Ž; Padaiga Ž
Medicina (Kaunas); 2015; 51(1):63-8. PubMed ID: 25744777
[TBL] [Abstract][Full Text] [Related]
9. The costs of heart failure in Poland from the public payer's perspective. Polish programme assessing diagnostic procedures, treatment and costs in patients with heart failure in randomly selected outpatient clinics and hospitals at different levels of care: POLKARD.
Czech M; Opolski G; Zdrojewski T; Dubiel JS; Wizner B; Bolisęga D; Fedyk-Łukasik M; Grodzicki T
Kardiol Pol; 2013; 71(3):224-32. PubMed ID: 23575775
[TBL] [Abstract][Full Text] [Related]
10. Indirect costs and public finance consequences of heart failure in Poland, 2012-2015.
Łyszczarz B
BMC Public Health; 2018 Sep; 18(1):1130. PubMed ID: 30231932
[TBL] [Abstract][Full Text] [Related]
11. Price tag of glaucoma care is minor compared with the total direct and indirect costs of glaucoma: Results from nationwide survey and register data.
Purola PKM; Taipale J; Väätäinen S; Harju M; Koskinen SVP; Uusitalo HMT
PLoS One; 2023; 18(12):e0295523. PubMed ID: 38117760
[TBL] [Abstract][Full Text] [Related]
12. Economic burden of breast cancer in northern Serbia.
Milovic M; Tamas T; Crnobrnja V; Paut Kusturica M
Front Public Health; 2023; 11():1265301. PubMed ID: 38162600
[TBL] [Abstract][Full Text] [Related]
13. The indirect costs of cancer-related absenteeism in the workplace in Poland.
Macioch T; Hermanowski T
J Occup Environ Med; 2011 Dec; 53(12):1472-7. PubMed ID: 22045222
[TBL] [Abstract][Full Text] [Related]
14. Indirect costs and incidence of caregivers' short-term absenteeism in Poland, 2006-2016.
Łyszczarz B
BMC Public Health; 2019 May; 19(1):598. PubMed ID: 31101035
[TBL] [Abstract][Full Text] [Related]
15. Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland.
Holko P; Kawalec P; Mossakowska M; Pilc A
PLoS One; 2016; 11(12):e0168586. PubMed ID: 27992531
[TBL] [Abstract][Full Text] [Related]
16. Indirect costs of diabetes and its impact on the public finance: the case of Poland.
Torój A; Mela A
Expert Rev Pharmacoecon Outcomes Res; 2018 Feb; 18(1):93-105. PubMed ID: 28796563
[TBL] [Abstract][Full Text] [Related]
17. [The expected cost of cancer in Chile].
Espinoza MA; Armijo N; Abbott T; Jiménez J; Balmaceda C
Rev Med Chil; 2022 Nov; 150(11):1438-1449. PubMed ID: 37358169
[TBL] [Abstract][Full Text] [Related]
18. Estimation of the Social Costs of Illegal Drug Use in Poland Using Standardized Methodology.
Mielecka-Kubie ZJ
J Ment Health Policy Econ; 2020 Sep; 23(3):139-149. PubMed ID: 33411676
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the burden of diabetes in Poland].
Kissimova-Skarbek K; Pach D; Płaczkiewicz E; Szurkowska M; Szybiński Z
Pol Arch Med Wewn; 2001 Sep; 106(3):867-73. PubMed ID: 11928598
[TBL] [Abstract][Full Text] [Related]
20. The societal costs of chronic pain and its determinants: The case of Austria.
Mayer S; Spickschen J; Stein KV; Crevenna R; Dorner TE; Simon J
PLoS One; 2019; 14(3):e0213889. PubMed ID: 30893370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
